Efficacy of individual and group hypnotherapy in irritable bowel syndrome (IMAGINE): a multicentre randomised controlled trial.

Published on Jan 1, 2019in The Lancet Gastroenterology & Hepatology14.789
· DOI :10.1016/S2468-1253(18)30310-8
Carla E. Flik5
Estimated H-index: 5
,
Wijnand Laan16
Estimated H-index: 16
+ 5 AuthorsNiek J. de Wit32
Estimated H-index: 32
Sources
Abstract
Summary Background Hypnotherapy for irritable bowel syndrome (IBS) has been used primarily in patients with refractory symptoms in specialised departments and delivered on an individual basis. We aimed to test the hypothesis that hypnotherapy would be more effective than educational supportive therapy, and that group hypnotherapy would be non-inferior to individual hypnotherapy for patients with IBS referred from primary and secondary care. Methods We did a multicentre randomised controlled trial (IMAGINE) in 11 hospitals in the Netherlands. Patients with IBS, aged 18–65 years, who were referred from primary or secondary care were randomly allocated (3:3:1) in blocks of six using a computer-based random number table procedure by staff not involved in the treatment to receive six sessions of individual or group hypnotherapy or group educational supportive therapy (control group). The primary outcome was adequate relief of IBS symptoms, with responders defined as patients who reported adequate relief when asked once weekly on three or four occasions in 4 consecutive weeks. We compared hypnotherapy (both groups) with control in the intention-to-treat population (excluding individuals subsequently found to be ineligible for enrolment), and assessed non-inferiority of group hypnotherapy versus individual hypnotherapy in the per-protocol population (with a non-inferiority margin of 15%) at 3 months and 12 months. This trial is registered with ISRCTN, number ISRCTN22888906, and is completed. Findings Between May 31, 2011, and April 6, 2016, 494 patients referred for psychological treatment for IBS were assessed for eligibility, of whom 354 were randomly allocated to the three groups: 150 to individual hypnotherapy, 150 to group hypnotherapy, and 54 to educational supportive therapy. After exclusion of individuals subsequently found to be ineligible for enrolment, 142 patients in the individual hypnotherapy group, 146 in the group hypnotherapy group, and 54 in the control group were included in the intention-to-treat population. Of these, 22 (15%) patients in the individual hypnotherapy group, 22 (15%) in the group hypnotherapy group, and 11 (20%) in the control group dropped out before or during therapy. In the intention-to-treat analysis, the adequate response rate was 40·8% (95% CI 31·7–50·5) in the individual hypnotherapy group, 33·2% (24·3–43·5) in the group hypnotherapy group, and 16·7% (7·6–32·6) in the control group at 3 months. At 12 months, 40·8% (31·3–51·1) of patients in the individual hypnotherapy group, 49·5% (38·8–60·0) of patients in the group hypnotherapy group, and 22.6% (11·5–39·5) of patients in the control group reported adequate relief. Hypnotherapy was more effective than control at 3 months (odds ratio 2·9, 95% CI 1·2–7·4, p=0·0240) and 12 months (2·8, 1·2–6·7, p=0·0185). In the per-protocol analysis, 49·9% (39·2–60·6) in the individual hypnotherapy group and 42·7% (32·3–53·8) in the group hypnotherapy group had adequate relief at 3 months, and 55·5% (43·4–67·1) of individual and 51·7% (40·2–63·0) of group hypnotherapy patients reported adequate relief at 12 months. Group hypnotherapy was therefore non-inferior to individual hypnotherapy. Eight unexpected serious adverse reactions (six in the individual hypnotherapy group and two in the group hypnotherapy group) were reported, most of which were cancer or inflammatory bowel disease, and were judged by the medical ethics committee as not being related to the therapy. Interpretation Hypnotherapy should be considered as a possible treatment for patients with IBS in primary and secondary care. Furthermore, group therapy could allow many more patients to be treated for the same cost. Funding None.
📖 Papers frequently viewed together
201219.82Gut
4 Authors (V S Hegade, ..., M Denyer)
1 Citations
61 Citations
References49
Newest
#1Carla E. FlikH-Index: 5
#2Laura BakkerH-Index: 1
Last. Niek J. de WitH-Index: 32
view all 6 authors...
Systematic review: The placebo effect of psychological interventions in the treatment of irritable bowel syndrome
20 CitationsSource
#1Carla E. FlikH-Index: 5
#2Wijnand LaanH-Index: 16
Last. Niek J. de WitH-Index: 32
view all 5 authors...
Background Irritable Bowel Syndrome (IBS) is a functional somatic syndrome characterized by patterns of persistent bodily complaints for which a thorough diagnostic workup does not reveal adequate explanatory structural pathology. Detailed insight into disease-specific health-care costs is critical because it co-determines the societal impact of the disease, enables the assessment of cost-effectiveness of existing and new treatments, and facilitates choices in treatment policy. In the present st...
11 CitationsSource
BACKGROUND: Gut-focused hypnotherapy improves the symptoms of irritable bowel syndrome (IBS) with benefits being sustained for many years. Despite this, the technique has not been widely adopted by healthcare systems, possibly due to relatively small numbers in published studies and uncertainty about how it should be provided. AIM: To review the effect of hypnotherapy in a large cohort of refractory IBS patients. METHODS: One thousand IBS patients fulfilling Rome II criteria, mean age 51.6�years...
58 CitationsSource
The gold-standard study design to evaluate the effects of medical treatment is the randomized trial. Assignment to treatment groups is a random process, and baseline differences in prognostic factors are due to chance. Consequently, at baseline, both groups are expected to be statistically
48 CitationsSource
#1Alexander C. Ford (St James's University Hospital)H-Index: 86
#2Eamonn Martin QuigleyH-Index: 120
Last. Paul Moayyedi (McMaster University)H-Index: 115
view all 9 authors...
Effect of Antidepressants and Psychological Therapies, Including Hypnotherapy, in Irritable Bowel Syndrome: Systematic Review and Meta-Analysis
278 CitationsSource
#1Gabriele Moser (Medical University of Vienna)H-Index: 16
#2Silja TrägnerH-Index: 1
Last. Wolfgang MiehslerH-Index: 26
view all 11 authors...
Long-Term Success of GUT-Directed Group Hypnosis for Patients With Refractory Irritable Bowel Syndrome: A Randomized Controlled Trial
80 CitationsSource
#1Charles D. Gerson (ISMMS: Icahn School of Medicine at Mount Sinai)H-Index: 12
#2Jessica Gerson (NYU: New York University)H-Index: 1
Last. Mary-Joan Gerson (NYU: New York University)H-Index: 8
view all 3 authors...
Abstract This study tested whether group gut-focused hypnotherapy would improve irritable bowel syndrome (IBS). Several possible outcome predictors were also studied. Before treatment, 75 patients completed a Symptom Severity Scale, a Mind–Body attribution questionnaire, and a Quality of Relationship Inventory (QRI). The symptom scale was completed posttreatment, 3, 6, and 12 months later. There was significant symptom reduction at each data point (p < .001). Sixty percent had a reduction of mor...
13 CitationsSource
#1Carla E. FlikH-Index: 5
#2Yanda R. van RoodH-Index: 14
Last. Niek J. de WitH-Index: 32
view all 7 authors...
Background Irritable Bowel Syndrome (IBS) is a common gastro-intestinal disorder in primary and secondary care, characterised by abdominal pain, discomfort, altered bowel habits and/or symptoms of bloating and distension. In general the efficacy of drug therapies is poor. Hypnotherapy as well as Cognitive Behaviour Therapy and short Psychodynamic Therapy appear to be useful options for patients with refractory IBS in secondary care and are cost-effective, but the evidence is still limited. The I...
12 CitationsSource
#1Alexander C. Ford (St James's University Hospital)H-Index: 86
#2Paul Moayyedi (McMaster University)H-Index: 115
Aliment Pharmacol Ther 2010; 32: 144–158 Summary Background Irritable bowel syndrome (IBS) is a functional disorder of the gastrointestinal tract with a significant placebo response. Aim To conduct a systematic review and meta-analysis examining the magnitude of placebo response rate in treatment trials for IBS. Methods MEDLINE, EMBASE and the Cochrane central register of controlled trials were searched to identify randomized controlled trials (RCTs) comparing pharmacological therapies with plac...
148 CitationsSource
#1Andrea Riedl (Charité)H-Index: 6
#2Julia Maass (Charité)H-Index: 1
Last. Hubert MönnikesH-Index: 19
view all 7 authors...
Abstract Objectives Patients' ideas about the nature, cause, and treatment of their illnesses are part of the complex process of coping with illness. To date, limited research on subjective theories of illness in patients with irritable bowel syndrome (IBS) has been performed. The aim of the study was to investigate patients' subjective theories of illness and how these are related to clinical and psychological outcome criteria, in particular IBS symptom severity and quality of life. Methods Eig...
23 CitationsSource
Cited By30
Newest
#1Wade Billings (IU: Indiana University)
#2Karan Mathur (IU: Indiana University)H-Index: 1
Last. Andrea Shin (IU: Indiana University)H-Index: 20
view all 5 authors...
Background & Aims Patients with irritable bowel syndrome (IBS) may pursue complementary and alternative medicine (CAM). We conducted a comprehensive systematic review and meta-analysis examining efficacy of CAM vs. placebo or sham in adults with IBS. Methods Publication databases were searched for randomized controlled trials of CAM therapies (herbal therapy, dietary supplements, mind-body based, body-based, and energy-healing) in adults with IBS. Data were extracted to obtain pooled estimates o...
1 CitationsSource
Irritable bowel syndrome (IBS) is a common disorder of gut-brain interaction which can have a considerable impact on quality of life. Following diagnosis, timely and evidence-based management is vital to the care of patients with IBS, aiming to improve outcomes, and enhance patient satisfaction. Good communication is paramount, and clinicians should provide a clear explanation about the disorder, with a focus on exploring the patient’s own beliefs about IBS, and a discussion of any concerns they...
Source
#1Dipesh H. Vasant (University of Manchester)H-Index: 10
#2Peter Paine (University of Salford)H-Index: 15
Last. Alexander C. Ford (St James's University Hospital)H-Index: 86
view all 13 authors...
Irritable bowel syndrome (IBS) remains one of the most common gastrointestinal disorders seen by clinicians in both primary and secondary care. Since publication of the last British Society of Gastroenterology (BSG) guideline in 2007, substantial advances have been made in understanding its complex pathophysiology, resulting in its re-classification as a disorder of gut-brain interaction, rather than a functional gastrointestinal disorder. Moreover, there has been a considerable amount of new ev...
4 CitationsSource
#1Hannibal Person (ISMMS: Icahn School of Medicine at Mount Sinai)H-Index: 2
#2Laurie Keefer (ISMMS: Icahn School of Medicine at Mount Sinai)H-Index: 40
Abstract The high comorbidity of psychological disorders in both functional and organic gastrointestinal diseases suggests the intimate and complex link between the brain and the gut. Termed the brain-gut axis, this bidirectional communication between the central nervous system and enteric nervous system relies on immune, endocrine, neural, and metabolic pathways. There is increasing evidence that the gut microbiome is a key part of this system, and dysregulation of the brain-gut-microbiome axis...
4 CitationsSource
#1Christopher J Black (St James's University Hospital)H-Index: 13
#2Alexander C. Ford (St James's University Hospital)H-Index: 86
Source
#1Nurul Afiedia Roslim (UniSZA: Universiti Sultan Zainal Abidin)
#2Aryati Ahmad (UniSZA: Universiti Sultan Zainal Abidin)H-Index: 5
Last. Pei Lin Lua (UniSZA: Universiti Sultan Zainal Abidin)H-Index: 13
view all 6 authors...
Objectives The global epidemic of overweight and obesity presents a major challenge in the health status of the society. Their prevalence is at an alarming rate worldwide due to poor compliance with conventional treatment and high rates of relapse, thus increasing demand for an effective and safe alternative approach such as hypnotherapy. This study aimed to evaluate the feasibility and acceptability of hypnotherapy for weight loss and to compare these among selected socio-demographics. Methods ...
Source
#1Matthew Krouwel (University of Birmingham)H-Index: 3
#2Amanda Farley (University of Birmingham)H-Index: 14
Last. Sheila Greenfield (University of Birmingham)H-Index: 37
view all 5 authors...
Abstract Background Hypnotherapy has been shown to be effective at relieving global gastrointestinal symptoms (GGS) in irritable bowel syndrome (IBS). This study examines the impact of hypnotherapy delivery and participant characteristics on IBS outcomes. Methods This systematic review searched CINAHL, Cochrane Library, Conference Citation Index, Embase, PubMed, PsycARTICLES, PsychINFO, Science Citation index-expanded, Social Science Citation Index. Titles and abstracts, then full-text articles ...
1 CitationsSource
#1Christopher Ma (U of C: University of Calgary)H-Index: 21
#2Stephen E. Congly (U of C: University of Calgary)H-Index: 9
Last. Yasmin Nasser (U of C: University of Calgary)H-Index: 10
view all 8 authors...
BACKGROUND & AIMS Functional bowel disorders (FBDs) are the most common gastrointestinal problems managed by physicians. We aimed to assess the burden of chronic symptomatic FBDs on ambulatory care delivery in the United States and evaluate patterns of treatment. METHODS Data from the National Ambulatory Medical Care Survey were used to estimate annual rates and associated costs of ambulatory visits for symptomatic irritable bowel syndrome, chronic functional abdominal pain, constipation, or dia...
6 CitationsSource
#1Shefaly Shorey (NUS: National University of Singapore)H-Index: 20
#2Alla Demutska (JCU: James Cook University)
Last. Kewin Tien Ho Siah (NUS: National University of Singapore)H-Index: 11
view all 4 authors...
Abstract Objective To consolidate existing qualitative studies which examined the experiences and needs of adults living with IBS, and to gather a holistic insight for future directions and avenues to support these adults. Methods A qualitative systematic review was conducted and six databases were searched for qualitative studies, beginning from each database's inception to July 2020. The qualitative data were meta-synthesised and thematic analysis was adopted. Any discrepancies that arose were...
2 CitationsSource
#1Brian E. LacyH-Index: 54
#2Mark PimentelH-Index: 61
Last. Baha Moshiree (UNC: University of North Carolina at Chapel Hill)H-Index: 2
view all 7 authors...
Irritable bowel syndrome (IBS) is a highly prevalent, chronic disorder that significantly reduces patients' quality of life. Advances in diagnostic testing and in therapeutic options for patients with IBS led to the development of this first-ever American College of Gastroenterology clinical guideline for the management of IBS using Grading of Recommendations, Assessment, Development, and Evaluation (GRADE) methodology. Twenty-five clinically important questions were assessed after a comprehensi...
35 CitationsSource